254 related articles for article (PubMed ID: 27650356)
1. Long-term auditory complications after childhood cancer: A report from the Swiss Childhood Cancer Survivor Study.
Weiss A; Sommer G; Kasteler R; Scheinemann K; Grotzer M; Kompis M; Kuehni CE;
Pediatr Blood Cancer; 2017 Feb; 64(2):364-373. PubMed ID: 27650356
[TBL] [Abstract][Full Text] [Related]
2. Auditory complications in childhood cancer survivors: a report from the childhood cancer survivor study.
Whelan K; Stratton K; Kawashima T; Leisenring W; Hayashi S; Waterbor J; Blatt J; Sklar CA; Packer R; Mitby P; Robison LL; Mertens AC
Pediatr Blood Cancer; 2011 Jul; 57(1):126-34. PubMed ID: 21328523
[TBL] [Abstract][Full Text] [Related]
3. Platinum-induced hearing loss after treatment for childhood cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010181. PubMed ID: 27486906
[TBL] [Abstract][Full Text] [Related]
4. Hearing loss after platinum treatment is irreversible in noncranial irradiated childhood cancer survivors.
Clemens E; de Vries AC; Am Zehnhoff-Dinnesen A; Tissing WJ; Loonen JJ; Pluijm SF; van Dulmen-den Broeder E; Bresters D; Versluys B; Kremer LC; van der Pal HJ; Neggers SJ; van Grotel M; M van den Heuvel-Eibrink M
Pediatr Hematol Oncol; 2017 Mar; 34(2):120-129. PubMed ID: 28590156
[TBL] [Abstract][Full Text] [Related]
5. Validation of questionnaire-reported hearing with medical records: A report from the Swiss Childhood Cancer Survivor Study.
Weiss A; Sommer G; Kuonen R; Scheinemann K; Grotzer M; Kompis M; Kuehni CE;
PLoS One; 2017; 12(3):e0174479. PubMed ID: 28333999
[TBL] [Abstract][Full Text] [Related]
6. Association of Hearing Impairment With Neurocognition in Survivors of Childhood Cancer.
Bass JK; Liu W; Banerjee P; Brinkman TM; Mulrooney DA; Gajjar A; Pappo AS; Merchant TE; Armstrong GT; Srivastava D; Robison LL; Hudson MM; Krull KR
JAMA Oncol; 2020 Sep; 6(9):1363-1371. PubMed ID: 32729886
[TBL] [Abstract][Full Text] [Related]
7. Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study.
Clemens E; de Vries AC; Pluijm SF; Am Zehnhoff-Dinnesen A; Tissing WJ; Loonen JJ; van Dulmen-den Broeder E; Bresters D; Versluys B; Kremer LC; van der Pal HJ; van Grotel M; van den Heuvel-Eibrink MM;
Eur J Cancer; 2016 Dec; 69():77-85. PubMed ID: 27821322
[TBL] [Abstract][Full Text] [Related]
8. Severity of hearing loss after platinum chemotherapy in childhood cancer survivors.
Strebel S; Mader L; Sláma T; Waespe N; Weiss A; Parfitt R; Am Zehnhoff-Dinnesen A; Kompis M; von der Weid NX; Ansari M; Kuehni CE
Pediatr Blood Cancer; 2022 Sep; 69(9):e29755. PubMed ID: 35723448
[TBL] [Abstract][Full Text] [Related]
9. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort.
Gibson TM; Mostoufi-Moab S; Stratton KL; Leisenring WM; Barnea D; Chow EJ; Donaldson SS; Howell RM; Hudson MM; Mahajan A; Nathan PC; Ness KK; Sklar CA; Tonorezos ES; Weldon CB; Wells EM; Yasui Y; Armstrong GT; Robison LL; Oeffinger KC
Lancet Oncol; 2018 Dec; 19(12):1590-1601. PubMed ID: 30416076
[TBL] [Abstract][Full Text] [Related]
10. Incidence and associated risk factors for platinum-induced ototoxicity in pediatric patients.
Waissbluth S; Del Valle Á; Chuang A; Becker A
Int J Pediatr Otorhinolaryngol; 2018 Aug; 111():174-179. PubMed ID: 29958605
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study.
Langer T; Clemens E; Broer L; Maier L; Uitterlinden AG; de Vries ACH; van Grotel M; Pluijm SFM; Binder H; Mayer B; von dem Knesebeck A; Byrne J; van Dulmen-den Broeder E; Crocco M; Grabow D; Kaatsch P; Kaiser M; Spix C; Kenborg L; Winther JF; Rechnitzer C; Hasle H; Kepak T; van der Kooi AF; Kremer LC; Kruseova J; Bielack S; Sorg B; Hecker-Nolting S; Kuehni CE; Ansari M; Kompis M; van der Pal H; Parfitt R; Deuster D; Matulat P; Tillmanns A; Tissing WJE; Beck JD; Elsner S; Am Zehnhoff-Dinnesen A; van den Heuvel-Eibrink MM; Zolk O;
Eur J Cancer; 2020 Oct; 138():212-224. PubMed ID: 32905960
[TBL] [Abstract][Full Text] [Related]
12. Audiological monitoring in Swiss childhood cancer patients.
Weiss A; Kuonen R; Brockmeier H; Grotzer M; Candreia C; Maire R; Senn P; Stieger C; Rosenfeld J; Veraguth D; Kompis M; Scheinemann K; Kuehni CE;
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29230928
[TBL] [Abstract][Full Text] [Related]
13. Hearing loss and quality of life in survivors of paediatric CNS tumours and other cancers.
Weiss A; Sommer G; Schindera C; Wengenroth L; Karow A; Diezi M; Michel G; Kuehni CE;
Qual Life Res; 2019 Feb; 28(2):515-521. PubMed ID: 30306534
[TBL] [Abstract][Full Text] [Related]
14. Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor Study.
King AA; Seidel K; Di C; Leisenring WM; Perkins SM; Krull KR; Sklar CA; Green DM; Armstrong GT; Zeltzer LK; Wells E; Stovall M; Ullrich NJ; Oeffinger KC; Robison LL; Packer RJ
Neuro Oncol; 2017 May; 19(5):689-698. PubMed ID: 28039368
[TBL] [Abstract][Full Text] [Related]
15. Incidence of childhood hearing loss after in utero exposure to platinum agents.
Finch LE; Cardonick EH
Prenat Diagn; 2021 Oct; 41(11):1467-1474. PubMed ID: 34462927
[TBL] [Abstract][Full Text] [Related]
16. Hearing loss among survivors of childhood brain tumors treated with an irradiation-sparing approach.
Orgel E; Jain S; Ji L; Pollick L; Si S; Finlay J; Freyer DR
Pediatr Blood Cancer; 2012 Jun; 58(6):953-8. PubMed ID: 21796767
[TBL] [Abstract][Full Text] [Related]
17. Concentration, working speed and memory: cognitive problems in young childhood cancer survivors and their siblings.
Wengenroth L; Rueegg CS; Michel G; Gianinazzi ME; Essig S; von der Weid NX; Grotzer M; Kuehni CE;
Pediatr Blood Cancer; 2015 May; 62(5):875-82. PubMed ID: 25645276
[TBL] [Abstract][Full Text] [Related]
18. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
19. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss.
Bertolini P; Lassalle M; Mercier G; Raquin MA; Izzi G; Corradini N; Hartmann O
J Pediatr Hematol Oncol; 2004 Oct; 26(10):649-55. PubMed ID: 15454836
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study.
Armstrong GT; Liu Q; Yasui Y; Huang S; Ness KK; Leisenring W; Hudson MM; Donaldson SS; King AA; Stovall M; Krull KR; Robison LL; Packer RJ
J Natl Cancer Inst; 2009 Jul; 101(13):946-58. PubMed ID: 19535780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
